Essential Healthcare News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Essential Healthcare News.

Press releases published on October 14, 2026

11 hours ago

Competitive Landscape of the Plasma Fractionation Market Examined Among Top Global Companies

Indeterminate EIN Presswire

11 hours ago

Cloud-Clone Publishes Guide for Protein-Detection Platform Selection to Solve Common Laboratory Bottlenecks

Indeterminate EIN Presswire

11 hours ago

Cloud-Clone Releases Comprehensive Guidance to Mitigate Common ELISA Pitfalls and Stabilise Assay Performance

Indeterminate EIN Presswire

11 hours ago

Outlook for the Oral Care Market Improves as Global Demand Increases

Indeterminate EIN Presswire

11 hours ago

CARE Project and LympheDIVAS Donate Nearly $100,000 in Compression Garments to Breast Cancer Survivors

Indeterminate EIN Presswire

11 hours ago

Analysis of Mental Health Market Trends and Forecasts Highlights Significant Long-Term Growth Potential

Indeterminate EIN Presswire

29 minutes ago

Invivyd and the SPEAR Study Group Announce Initiation of “FLINTLOCK” Phase 2 Study of VYD2311, a Monoclonal Antibody for the Potential Treatment of Long COVID or Post-Vaccination Syndrome

Indeterminate GlobeNewswire

29 minutes ago

BreathiZen Introduces BreathiZen Spray With Mullein Leaf Extract, Ginger Root Extract, Bromelain, and Organic Lemon Extract 60 ml

Indeterminate GlobeNewswire

30 minutes ago

Axogen, Inc. to Report Third Quarter 2026 Financial Results on October 28, 2026

Indeterminate GlobeNewswire

30 minutes ago

Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 3 at the Top Dose of 18 mg/kg in Entrada Therapeutics’ ELEVATE-44-201 Study

Indeterminate GlobeNewswire

30 minutes ago

Matchpoint Therapeutics Expands Leadership Team with Appointment of John O’Malley, M.D., Ph.D., as Chief Medical Officer

Indeterminate GlobeNewswire

30 minutes ago

Orvida Pharma Announces FDA Acceptance of KM-023 (ontivatrep) into Rare Disease Evidence Principles Process for Olmsted Syndrome

Indeterminate GlobeNewswire

30 minutes ago

Entrada Therapeutics Announces Positive Results from the First Cohort of Participants with Duchenne Muscular Dystrophy (DMD) in the Phase 1/2 ELEVATE-45-201 Study of ENTR-601-45

Indeterminate GlobeNewswire

30 minutes ago

Arexera Therapeutics, Formerly Atalanta Therapeutics, Unveils New Corporate Identity and Advances Huntington's Disease Franchise

Indeterminate GlobeNewswire

30 minutes ago

Elion Therapeutics Expands Pipeline with Exclusive Global License to Inhaled Antifungal for Immunocompromised Patients

Indeterminate GlobeNewswire

30 minutes ago

Parabilis Medicines Initiates Dose-Ranging Clinical Study of Zolucatetide in Familial Adenomatous Polyposis

Indeterminate GlobeNewswire

40 minutes ago

Eton Pharmaceuticals and Aquestive Therapeutics Announce Exclusive U.S. Licensing Agreement for LIBERVANT® (diazepam) Buccal Film

Indeterminate GlobeNewswire

an hour ago

Ocugen and Roots Pharmaceutical Complete License Agreement for OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in the Middle East and North Africa

Indeterminate GlobeNewswire

an hour ago

Quoin Pharmaceuticals Announces European Medicines Agency (EMA) Grants Orphan Drug Designation for QRX003 for the Treatment of Peeling Skin Syndrome

Indeterminate GlobeNewswire

2 hours ago

Rakovina Therapeutics Secures Exclusivity on Optimized kt-5000 Lead Profile from Variational AI

Indeterminate GlobeNewswire